For a hedged play on Perrigo (PRGO), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Jun 15, 2018 $75 covered call for a net debit in the $73 area. That is also the break-even stock price for the covered call. …
Mr. Rolf A. Classon serves as Independent Director of Perrigo Company Public Limited Company effective May 2, 2017. Mr. Classon served as Interim President and Chief Executive Officer of Hillenbrand Industries, a global diversified …
At this time, PRGO has a nice Growth Score of B, though it is lagging a lot on the momentum front with an F. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy. Overall ...
In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued …
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Perrigo (PRGO) today after it ... as long as the stock closes above $75 at expiration.
On May 14, Teva (TEVA) stock increased ~5.5% on the news of the expected delay in the FDA approval for rival Perrigo’s (PRGO) generic version of Teva’s asthma inhaler ProAir. On May 14, Teva stock closed at a trading price of $20.38 per …
Ms. Marry Laurie Brlas is Independent Chairman of the Board of Perrigo Company Public Limited Company. She has been a director of Perrigo since August 2003 and was appointed Chairman of the Board in April 2016. Ms. Brlas served as …
Perrigo’s stock fell, losing 4.4 percent after the markets closed ... and adjusted EPS guidance to be in the range of $5.05 to $5.45 for the year. Perrigo (PRGO) misses earnings estimates but exceeds revenue expectations in Q1. The …